Health technology company Seqster announced Thursday the launch of its new 1-Click Sites platform, tapping BioIVT as its ...
An FDA review of records in the U.S. clinical trials database shows that results have not been reported for 30% of clinical ...
Cantargia AB (Publ) (Nasdaq Stockholm:CANTA) today reported that the rationale and study design of the phase 1b/2 clinical trial investigating nadunolimab in combination with immune-checkpoint ...
PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
By combining our platform with Trialt’s expertise, we can support sponsors with both the technology and the operational ...
Clinical site selection platform RyghtAI has launched a search engine designed to give drug developers and contract research ...
SEQSTER Enters Partnership with BioIVT to Expand Access to High-Quality Clinical and Biological Data Clinical research ...
Eli Lilly (LLY) stock climbs 3% after Foundayo's debut week prescriptions reach 1,390 and trial shows significant ...
FDA officials said an internal analysis found results were not submitted for nearly 30% of studies “highly likely” to fall ...
Azetukalner data show significant reductions in seizure frequency across weekly, monthly and multi-year time pointsX-TOLE2 data featured in Late-breaking Science session show 53.2% reduction in ...
Trial Designed to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SEP-479 in Healthy Volunteers Data Anticipated in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results